JP2025510911A - 精神障害の治療 - Google Patents
精神障害の治療 Download PDFInfo
- Publication number
- JP2025510911A JP2025510911A JP2024557189A JP2024557189A JP2025510911A JP 2025510911 A JP2025510911 A JP 2025510911A JP 2024557189 A JP2024557189 A JP 2024557189A JP 2024557189 A JP2024557189 A JP 2024557189A JP 2025510911 A JP2025510911 A JP 2025510911A
- Authority
- JP
- Japan
- Prior art keywords
- dmt
- meo
- pharma
- acceptable salt
- disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22000083.0 | 2022-03-27 | ||
| EP22000086 | 2022-03-27 | ||
| EP22000086.3 | 2022-03-27 | ||
| EP22000083 | 2022-03-27 | ||
| EP23153995.8 | 2023-01-30 | ||
| EP23153939 | 2023-01-30 | ||
| EP23153995 | 2023-01-30 | ||
| EP23153939.6 | 2023-01-30 | ||
| PCT/EP2023/057883 WO2023186835A1 (en) | 2022-03-27 | 2023-03-27 | Treatment of mental disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025510911A true JP2025510911A (ja) | 2025-04-15 |
| JP2025510911A5 JP2025510911A5 (enExample) | 2026-04-08 |
Family
ID=93292079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024557189A Pending JP2025510911A (ja) | 2022-03-27 | 2023-03-27 | 精神障害の治療 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250241894A1 (enExample) |
| EP (1) | EP4499086A1 (enExample) |
| JP (1) | JP2025510911A (enExample) |
| KR (1) | KR20250005172A (enExample) |
| AU (1) | AU2023246680A1 (enExample) |
| CA (1) | CA3255635A1 (enExample) |
| IL (1) | IL315890A (enExample) |
-
2023
- 2023-03-27 US US18/850,394 patent/US20250241894A1/en active Pending
- 2023-03-27 JP JP2024557189A patent/JP2025510911A/ja active Pending
- 2023-03-27 EP EP23717047.7A patent/EP4499086A1/en active Pending
- 2023-03-27 CA CA3255635A patent/CA3255635A1/en active Pending
- 2023-03-27 IL IL315890A patent/IL315890A/en unknown
- 2023-03-27 AU AU2023246680A patent/AU2023246680A1/en active Pending
- 2023-03-27 KR KR1020247035656A patent/KR20250005172A/ko active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20250241894A1 (en) | 2025-07-31 |
| IL315890A (en) | 2024-11-01 |
| CA3255635A1 (en) | 2023-10-05 |
| AU2023246680A1 (en) | 2024-11-07 |
| EP4499086A1 (en) | 2025-02-05 |
| KR20250005172A (ko) | 2025-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025510914A (ja) | 産後うつ病の治療 | |
| WO2023186835A1 (en) | Treatment of mental disorders | |
| KR20250139377A (ko) | 수유부의 정신 장애 치료에 사용하기 위한 5-메톡시-n,n-다이메틸트립타민 | |
| KR20250138805A (ko) | 정신 장애의 치료 | |
| JP2025510911A (ja) | 精神障害の治療 | |
| CN118973568A (zh) | 精神障碍的治疗 | |
| CN118973571A (zh) | 认知功能障碍的治疗 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260318 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20260318 |